• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dynavax Technologies Corporation - Common Stock (NQ:DVAX)

15.50 UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Dynavax Technologies Corporation - Common Stock

News headline image
Halper Sadeh LLC Encourages DVAX, FONR, DBRG, ONTF Shareholders to Contact the Firm to Discuss Their Rights
January 06, 2026
Shareholders should contact the firm as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
CORRECTING and REPLACING Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX
December 30, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
DVAX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Dynavax Technologies Corporation is Fair to Shareholders
December 24, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom
June 09, 2025
From Deep Track Capital, LP
Via Business Wire
News headline image
Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies
June 04, 2025
From Deep Track Capital, LP
Via Business Wire
News headline image
Deep Track Capital Comments on ISS Recommendation
May 23, 2025
From Deep Track Capital, LP
Via Business Wire
News headline image
Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting
May 15, 2025
From Deep Track Capital, LP
Via Business Wire
News headline image
Deep Track Capital Releases Investor Presentation on Dynavax Technologies
May 06, 2025
From Deep Track Capital, LP
Via Business Wire
News headline image
Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders
April 21, 2025
From Deep Track Capital, LP
Via Business Wire
News headline image
Deep Track Capital Comments on Dynavax Technologies’ Rejection of Most Recent Settlement Offer
April 16, 2025
From Deep Track Capital, LP
Via Business Wire
News headline image
Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors
March 10, 2025
From Deep Track Capital, LP
Via Business Wire
News headline image
Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
February 19, 2025
From Deep Track Capital, LP
Via Business Wire
News headline image
Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)
November 06, 2024
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Lantheus Appoints Julie Eastland as New Board Member
September 05, 2024
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023
January 15, 2023
From Clover Biopharmaceuticals
Via GlobeNewswire
News headline image
Clover’s Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases
November 30, 2022
From Clover Biopharmaceuticals
Via GlobeNewswire
News headline image
Clover Provides Update on 2022 Corporate Milestones
October 09, 2022
From Clover Biopharmaceuticals
Via GlobeNewswire
Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
April 21, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from... 
Via FinancialNewsMedia
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
October 20, 2021
Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing... 
Via FinancialNewsMedia
As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024
September 23, 2021
Via FinancialNewsMedia
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap